Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules, 2168-2174 [05-594]

Download as PDF 2168 Federal Register / Vol. 70, No. 8 / Wednesday, January 12, 2005 / Notices 2. Any items carried forward from a previously announced meeting. FOR FURTHER INFORMATION CONTACT: Michelle A. Smith, Director, Office of Board Members; 202–452–2955. SUPPLEMENTARY INFORMATION: You may call 202–452–3206 beginning at approximately 5 p.m. two business days before the meeting for a recorded announcement of bank and bank holding company applications scheduled for the meeting; or you may contact the Board’s Web site at https:// www.federalreserve.gov for an electronic announcement that not only lists applications, but also indicates procedural and other information about the meeting. Board of Governors of the Federal Reserve System, January 10, 2005. Robert dev. Frierson, Deputy Secretary of the Board. [FR Doc. 05–703 Filed 1–10–05; 11:23 am] FEDERAL TRADE COMMISSION Parts will be open to the public and parts closed to the public. Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules STATUS: MATTERS TO BE CONSIDERED: Parts Open to the Public 1. Approval of the minutes of the December 20, 2004, Board member meeting. 2. Thrift Savings Plan activity report by the Executive Director. 3. Investment policy quarterly review. Parts Closed to the Public 4. Procurement. 5. Personnel matters. CONTACT PERSON FOR MORE INFORMATION: Thomas J. Trabucco, Director, Office of External Affairs, (202) 942–1640. Dated: January 10, 2005. Elizabeth S. Woodruff, Secretary to the Board, Federal Retirement Thrift Investment Board. [FR Doc. 05–721 Filed 1–10–05; 12:56 pm] BILLING CODE 6210–01–S FEDERAL RETIREMENT THRIFT INVESTMENT BOARD BILLING CODE 6760–01–P Sunshine Act Notice TIME AND DATE: 4th Floor Conference Room, 1250 H Street, NW., Washington, DC. PLACE: 9 a.m. (EST), January 19, 2005. VerDate jul<14>2003 Section 7A of the Clayton Act, 15 U.S.C. 18a, as added by Title II of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, requires persons contemplating certain mergers or acquisitions to give the Federal Trade Commission and the Assistant Attorney General advance notice and to wait designated periods before consummation of such plans. Section 7A(b)(2) of the Act permits the agencies, in individual cases, to terminate this waiting period prior to its expiration and requires that notice of this action be published in the Federal Register. The following transactions were granted early termination of the waiting period provided by law and the premerger notification rules. The grants were made by the Federal Trade Commission and the Assistant Attorney General for the Antitrust Division of the Department of Justice. Neither agency intends to take any action with respect to these proposed acquisitions during the applicable waiting period. BILLING CODE 6750–01–M 17:37 Jan 11, 2005 Jkt 205001 PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 E:\FR\FM\12JAN1.SGM 12JAN1 VerDate jul<14>2003 17:37 Jan 11, 2005 Jkt 205001 PO 00000 Frm 00061 Fmt 4703 Sfmt 4725 E:\FR\FM\12JAN1.SGM 12JAN1 2169 EN12JA05.016</GPH> Federal Register / Vol. 70, No. 8 / Wednesday, January 12, 2005 / Notices VerDate jul<14>2003 Federal Register / Vol. 70, No. 8 / Wednesday, January 12, 2005 / Notices 17:37 Jan 11, 2005 Jkt 205001 PO 00000 Frm 00062 Fmt 4703 Sfmt 4725 E:\FR\FM\12JAN1.SGM 12JAN1 EN12JA05.017</GPH> 2170 VerDate jul<14>2003 17:37 Jan 11, 2005 Jkt 205001 PO 00000 Frm 00063 Fmt 4703 Sfmt 4725 E:\FR\FM\12JAN1.SGM 12JAN1 2171 EN12JA05.018</GPH> Federal Register / Vol. 70, No. 8 / Wednesday, January 12, 2005 / Notices VerDate jul<14>2003 Federal Register / Vol. 70, No. 8 / Wednesday, January 12, 2005 / Notices 17:37 Jan 11, 2005 Jkt 205001 PO 00000 Frm 00064 Fmt 4703 Sfmt 4725 E:\FR\FM\12JAN1.SGM 12JAN1 EN12JA05.019</GPH> 2172 VerDate jul<14>2003 17:37 Jan 11, 2005 Jkt 205001 PO 00000 Frm 00065 Fmt 4703 Sfmt 4725 E:\FR\FM\12JAN1.SGM 12JAN1 2173 EN12JA05.020</GPH> Federal Register / Vol. 70, No. 8 / Wednesday, January 12, 2005 / Notices 2174 FOR FURTHER INFORMATION CONTACT: Sandra M. Peay, Contact Representative or Renee Hallman, Case Management Assistant, Federal Trade Commission, Premerger Notification Office, Bureau of Competition, Room H–303, Washington, DC 20580, (202) 326–3100. By direction of the Commission. Donald S. Clark, Secretary. [FR Doc. 05–594 Filed 1–11–04; 8:45 am] BILLING CODE 6750–01–C DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2005N–0003] Agency Information Collection Activities; Proposed Collection; Comment Request; Prescription Drug Product Labeling; Medication Guide Requirements AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on VerDate jul<14>2003 17:37 Jan 11, 2005 Jkt 205001 regulations requiring the distribution of patient labeling, called Medication Guides, for certain products that pose a serious and significant public health concern requiring distribution of FDAapproved patient medication information. DATES: Submit written or electronic comments on the collection of information by March 14, 2005. ADDRESSES: Submit electronic comments on the collection of information to: https://www.fda.gov/ dockets/ecomments. Submit written comments on the collection of information to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Karen Nelson, Office of Management Programs (HFA–250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–827–1482. SUPPLEMENTARY INFORMATION: Under the PRA, (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. ‘‘Collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 including each proposed extension of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, FDA is publishing notice of the proposed collection of information set forth in this document. With respect to the following collection of information, FDA invites comments on these topics: (1) Whether the proposed collection of information is necessary for the proper performance of FDA’s functions, including whether the information will have practical utility; (2) the accuracy of FDA’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, when appropriate, and other forms of information technology. Prescription Drug Product Labeling; Medication Guide Requirements (OMB Control Number 0910–0393)—Extension FDA regulations require the distribution of Medication Guides for certain prescription human drug and biological products used primarily on an outpatient basis that pose a serious and significant public health concern requiring distribution of FDA-approved patient medication information. These Medication Guides inform patients about the most important information they should know about these products in order to use them safely and effectively. Included is information such as the drug’s approved uses, contraindications, adverse drug E:\FR\FM\12JAN1.SGM 12JAN1 EN12JA05.021</GPH> Federal Register / Vol. 70, No. 8 / Wednesday, January 12, 2005 / Notices

Agencies

[Federal Register Volume 70, Number 8 (Wednesday, January 12, 2005)]
[Notices]
[Pages 2168-2174]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-594]


=======================================================================
-----------------------------------------------------------------------

FEDERAL TRADE COMMISSION


Granting of Request for Early Termination of the Waiting Period 
Under the Premerger Notification Rules

    Section 7A of the Clayton Act, 15 U.S.C. 18a, as added by Title II 
of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, requires 
persons contemplating certain mergers or acquisitions to give the 
Federal Trade Commission and the Assistant Attorney General advance 
notice and to wait designated periods before consummation of such 
plans. Section 7A(b)(2) of the Act permits the agencies, in individual 
cases, to terminate this waiting period prior to its expiration and 
requires that notice of this action be published in the Federal 
Register.
    The following transactions were granted early termination of the 
waiting period provided by law and the premerger notification rules. 
The grants were made by the Federal Trade Commission and the Assistant 
Attorney General for the Antitrust Division of the Department of 
Justice. Neither agency intends to take any action with respect to 
these proposed acquisitions during the applicable waiting period.

BILLING CODE 6750-01-M

[[Page 2169]]

[GRAPHIC] [TIFF OMITTED] TN12JA05.016


[[Page 2170]]


[GRAPHIC] [TIFF OMITTED] TN12JA05.017


[[Page 2171]]


[GRAPHIC] [TIFF OMITTED] TN12JA05.018


[[Page 2172]]


[GRAPHIC] [TIFF OMITTED] TN12JA05.019


[[Page 2173]]


[GRAPHIC] [TIFF OMITTED] TN12JA05.020


[[Page 2174]]


[GRAPHIC] [TIFF OMITTED] TN12JA05.021


FOR FURTHER INFORMATION CONTACT: Sandra M. Peay, Contact Representative 
or Renee Hallman, Case Management Assistant, Federal Trade Commission, 
Premerger Notification Office, Bureau of Competition, Room H-303, 
Washington, DC 20580, (202) 326-3100.

    By direction of the Commission.

Donald S. Clark,
Secretary.
[FR Doc. 05-594 Filed 1-11-04; 8:45 am]
BILLING CODE 6750-01-C
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.